Designing gene circuits and programming cells for tremendous therapeutic value.

Senti Bio is a next-generation biotechnology company that designs gene circuits and programs cells for tremendous therapeutic value. Backed by a group of leading biotech and tech investors including Leaps by Bayer, NEA, 8VC and Matrix, and led by an experienced team with deep translational knowledge of advanced cell therapies, Senti Bio is leveraging its proprietary gene circuit repertoire to solve the most pressing unmet needs in oncology and other difficult disease areas. 

Press Releases | In the News